Market Outlook : Oncology Molecular Diagnostics Market Globally Grow at a CAGR of 17.8% by Revenue During the Period 2016-2019
Researchmoz added Most up-to-date research on "Global Oncology Molecular Diagnostics Market 2015-2019" to its huge collection of research reports.
About oncology molecular diagnostics
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
Technavio's analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
Breast
Colorectal
Prostate
Others (including lung and cervical cancers)
Technavio's report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=357234
Key regions
APAC
Europe
Latin America
MEA
North America
Key vendors
Abbott Diagnostics
Becton, Dickinson and Company
QIAGEN
Roche Diagnostics
Other prominent vendors
Agendia
Angsana Molecular and Diagnostics
Asuragen
Autogenomics
Beckman Coulter
bioMrieux
bioTheranostics (Formerly AviaraDx)
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
About oncology molecular diagnostics
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
Technavio's analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
Breast
Colorectal
Prostate
Others (including lung and cervical cancers)
Technavio's report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=357234
Key regions
APAC
Europe
Latin America
MEA
North America
Key vendors
Abbott Diagnostics
Becton, Dickinson and Company
QIAGEN
Roche Diagnostics
Other prominent vendors
Agendia
Angsana Molecular and Diagnostics
Asuragen
Autogenomics
Beckman Coulter
bioMrieux
bioTheranostics (Formerly AviaraDx)
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Comments
Post a Comment